Although the importance of cervical cancer prevention is well known, many human papillomavirus (HPV) vaccinations actually occur later than recommended.
Further, as young women continue to age, the forecastable health benefits of HPV vaccines diminish quickly.
Using data from the National Health and Nutrition Examination Survey to estimate the proportion of females who were vaccinated against HPV-16/18 prevalence before their sexual debut, researchers found vaccination by age 12 is estimated to prevent most lifetime cervical cancers caused by HPV-16/18.
Read More